As COVID-19 cases spike in a few States, what is causing a decline in Kerala?
Even as recently as March 6, March 4, March 3, March 2 and March 1 the Health Ministry mischievously implicated
Read More
Covaxin should no longer be available in ‘clinical trial mode’
The vaccine efficacy was measured based on symptomatic COVID-19 disease — mild, moderate or severe — two weeks after the
Read More
IGIB: In vaccinated people, Covishield first dose is highly immunogenic if already infected
The results have been posted on medRxiv preprint server. Preprints are yet to be peer-reviewed and published in scientific journals.
Read More
Doctors say comorbidities list for COVID-19 vaccination is highly restrictive
“The list of comorbidities provided by the Health Ministry is overly restrictive and complicated. Many conditions, including obesity, have been
Read More
Is India witnessing the beginning of the second wave?
From below 5%, the test positivity rate has suddenly shot up in Maharashtra — the seven-day average test positivity rate
Read More
Vaccinate all above 45 years to avoid vaccine inequities
Roping in the private sector to support the government programme of vaccinating about 270 million people belonging to the two
Read More
People above 45 years with comorbidities will need doctor certificate for COVID-19 vaccine, says task force member
Those older than 45 years and with comorbidities will need a certificate from a registered medical doctor. But those older than 60 years will not need any certificate. only Serum Institute’s Covishield vaccine will be available at private hospitals. Self-registration needed for those above 45 years with comorbidities.
Read More
Are the SARS-CoV-2 variants causing a spike in cases in India?
No spike in Kerala Contrary to claims made by the Health Ministry about a spike in Kerala, the daily fresh
Read More
Covaxin has only 10% takers nationally; less than 1% uptake in 12 States, Union Territories
On January 3, the Indian regulator approved Covaxin for restricted use “under clinical trial mode” as a matter of “abundant
Read More
Daily vaccination rate will soon increase exponentially, says task force member
On January 16, when the mass COVID-19 vaccination programme began in India, only 3,352 sessions were held and 0.19 million
Read More
Proving variant-specific efficacy will be a logistic nightmare, very expensive: Gagandeep Kang
The emergence of three variants — B.1.1.7 first found in Britain, B.1.1.248 first seen in Brazil, and B.1.351 first detected
Read More
Pfizer vaccine can be stored at -15 to -25 degree C for two weeks
On December 11, 2020 when the U.S. FDA approved the vaccine for emergency use, the storage temperature stipulated was -60
Read More
Explained: Probing the origin of SARS-CoV-2 virus
As per WHO, the field visits included the Wuhan Institute of Virology, Huanan market, Wuhan CDC (Center for Disease Control and Prevention)
Read More